{"title":"LHRH类似物在前列腺癌治疗中的作用","authors":"M. Zerbib, en collaboration avec A. Descazeaud","doi":"10.1016/S0003-4401(07)80516-X","DOIUrl":null,"url":null,"abstract":"<div><p>The contribution of LHRH analogs is enormous in prostate cancer management at nearly all stages of the disease, the leading cancer in males over 50 years of age. They make it possible to use hormone therapy reliably, with little morbidity, and can be reversed. Their use can be immediate or delayed, continuous or intermittent, whether or not they are associated with an antiandrogen, and can be associated with chemotherapy for patients who have reached the stage of hormone-refractory prostate cancer.</p></div>","PeriodicalId":50783,"journal":{"name":"Annales D Urologie","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2007-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0003-4401(07)80516-X","citationCount":"1","resultStr":"{\"title\":\"Apports des analogues de la LHRH dans le traitement du cancer de la prostate\",\"authors\":\"M. Zerbib, en collaboration avec A. Descazeaud\",\"doi\":\"10.1016/S0003-4401(07)80516-X\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>The contribution of LHRH analogs is enormous in prostate cancer management at nearly all stages of the disease, the leading cancer in males over 50 years of age. They make it possible to use hormone therapy reliably, with little morbidity, and can be reversed. Their use can be immediate or delayed, continuous or intermittent, whether or not they are associated with an antiandrogen, and can be associated with chemotherapy for patients who have reached the stage of hormone-refractory prostate cancer.</p></div>\",\"PeriodicalId\":50783,\"journal\":{\"name\":\"Annales D Urologie\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2007-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/S0003-4401(07)80516-X\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Annales D Urologie\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S000344010780516X\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annales D Urologie","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S000344010780516X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Apports des analogues de la LHRH dans le traitement du cancer de la prostate
The contribution of LHRH analogs is enormous in prostate cancer management at nearly all stages of the disease, the leading cancer in males over 50 years of age. They make it possible to use hormone therapy reliably, with little morbidity, and can be reversed. Their use can be immediate or delayed, continuous or intermittent, whether or not they are associated with an antiandrogen, and can be associated with chemotherapy for patients who have reached the stage of hormone-refractory prostate cancer.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
